On this episode of Brains Behind AI, Ari had the opportunity to chat with Dr. Abraham Heifets, the CEO and Co-Founder of Atomiwse, where he invented the use of deep convolutional neural networks for drug discovery. Abe’s doctoral work applied machine learning and classical AI techniques to organic synthesis planning, which is a long-standing challenge in chemistry. His vision of Artificial Intelligence bringing better, safe, and more potent drugs to patients has become a reality, and Atomwise...
All content for Brains Behind AI is the property of Ari Yacobi and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
On this episode of Brains Behind AI, Ari had the opportunity to chat with Dr. Abraham Heifets, the CEO and Co-Founder of Atomiwse, where he invented the use of deep convolutional neural networks for drug discovery. Abe’s doctoral work applied machine learning and classical AI techniques to organic synthesis planning, which is a long-standing challenge in chemistry. His vision of Artificial Intelligence bringing better, safe, and more potent drugs to patients has become a reality, and Atomwise...
AI.Reverie: Daeil Kim On Building Virtual Worlds to Train Computer Vision Applications for Smarter AI
Brains Behind AI
35 minutes
4 years ago
AI.Reverie: Daeil Kim On Building Virtual Worlds to Train Computer Vision Applications for Smarter AI
On our 18th Episode of “Brains Behind AI”, Ari and Natalie had the pleasure of speaking with Daeil Kim, the technical founder of AI.Reverie. AI.Reverie is a simulation platform that trains AI to understand the world, and was ranked by Forbes as one of the top 25 Machine Learning companies to look out for in 2020. With a PhD in computer science from Brown University, Daeil focused on the development of scalable machine learning algorithms, he believes that we can create a future where issues r...
Brains Behind AI
On this episode of Brains Behind AI, Ari had the opportunity to chat with Dr. Abraham Heifets, the CEO and Co-Founder of Atomiwse, where he invented the use of deep convolutional neural networks for drug discovery. Abe’s doctoral work applied machine learning and classical AI techniques to organic synthesis planning, which is a long-standing challenge in chemistry. His vision of Artificial Intelligence bringing better, safe, and more potent drugs to patients has become a reality, and Atomwise...
